Skip to main navigation Skip to search Skip to main content

Targeting pediatric solid tumors in the new era of RNA therapeutics

  • Faculty of Medicine, Chiang Mai University
  • University of Cincinnati College of Medicine
  • Faculty of Medicine, Prince of Songkla University
  • Mahidol University
  • Faculty of Medicine Ramathibodi Hospital, Mahidol University
  • Ramathibodi Hospital

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

Despite substantial progress in pediatric cancer treatment, poor prognosis remained for patients with recurrent or metastatic disease, given the limitations of approved targeted treatments and immunotherapies. RNA therapeutics offer significant potential for addressing a broad spectrum of diseases, including cancer. Advances in manufacturing and delivery systems are paving the way for the rapid development of therapeutic RNAs for clinical applications. This review summarizes therapeutic RNA classifications and the mechanisms of action, highlighting their potential in manipulating major cancer-related pathways and biological effects. We also focus on the pre-clinical investigation of RNA molecules with efficient delivery systems for their therapeutic potential targeting pediatric solid tumors.

Original languageEnglish
Article number104406
JournalCritical Reviews in Oncology/Hematology
Volume200
DOIs
Publication statusPublished - Aug 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords

  • Childhood cancer
  • Delivery
  • Mechanism of action
  • Precision medicine
  • RNA drugs
  • Therapeutics

Fingerprint

Dive into the research topics of 'Targeting pediatric solid tumors in the new era of RNA therapeutics'. Together they form a unique fingerprint.

Cite this